Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 21 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Completed
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
NCT00939627
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Suburban Hospital Bethesda, Maryland, United States
NCT02245100
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +50 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT01847326
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03032250
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Caregiver, +44 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT01816984
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT01044433
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +30 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01254617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +66 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
NCT01469429
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +86 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00055913
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +18 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
NCT02035527
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +50 more
- Locations
-
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States